Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports

Chloroquine (CQ) and hydroxychloroquine (HCQ) are on the World Health Organization’s List of Essential Medications for treating non-resistant malaria, rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). In addition, both drugs are currently used off-label in hospitals worldwide and in...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Isaac V., Makunts, Tigran, Moumedjian, Talar, Issa, Masara A., Abagyan, Ruben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644696/
https://www.ncbi.nlm.nih.gov/pubmed/33154498
http://dx.doi.org/10.1038/s41598-020-76258-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644696/
https://www.ncbi.nlm.nih.gov/pubmed/33154498
http://dx.doi.org/10.1038/s41598-020-76258-0

Ejemplares similares